Clinical Trial Update: EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA [Phase 4]

View source ↗

Summary

Phase 4 trial comparing starting Aggrenox within 24 hours of ischemic stroke onset versus starting after one week; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Aggrenox (aspirin and dipyridamole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Cerebrovascular Accident | Phase 4 | Status: COMPLETED | Results posted: 2010-03-11